Prevail Global Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1205 participants.
Also called NCT06535854
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,205 participants
- Sponsor
- Registry
-
NCT06535854
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Germany, Hong Kong SAR China, Ireland, Japan, Singapore, South Korea, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06535854. Randomized; single masking; primary purpose treatment. Start 2025-02-24 (actual); primary completion 2027-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevail Global Study
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Prevail DCB
- Intervention (Device)
- Agent DCB
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct06535854- Content hash
275d99a926329bc93234183af09fd6166d824500bdb7ce7d05a7810735ebbdb1